Last reviewed · How we verify
transdermal therapeutic system- nicotine. — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
transdermal therapeutic system- nicotine. (transdermal therapeutic system- nicotine.) — Ain Shams University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| transdermal therapeutic system- nicotine. TARGET | transdermal therapeutic system- nicotine. | Ain Shams University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- transdermal therapeutic system- nicotine. CI watch — RSS
- transdermal therapeutic system- nicotine. CI watch — Atom
- transdermal therapeutic system- nicotine. CI watch — JSON
- transdermal therapeutic system- nicotine. alone — RSS
Cite this brief
Drug Landscape (2026). transdermal therapeutic system- nicotine. — Competitive Intelligence Brief. https://druglandscape.com/ci/transdermal-therapeutic-system-nicotine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab